Govt expands use of anti-malaria drug to curb transmission

Govt expands use of anti-malaria drug to curb transmission

Hindustan Times

Even as medical journal The Lancet published a paper on Friday saying there were no confirmed benefits of anti-malarial drug hydroxychloroquine (HCQ) being given to Covid-19 patients, the Union health ministry issued an advisory expanding the pool of people to be given the medicine as a prophylactic to prevent them from contracting the infection.

'The Joint Monitoring Group and National Task Force have now recommended the prophylactic use of HCQ in the following categories: a) all asymptomatic healthcare workers involved in containment and treatment of Covid-19 and asymptomatic healthcare workers working in non-covid hospitals/non-covid areas of covid hospitals/blocks; b) Asymptomatic frontline workers, such as surveillance workers deployed in containment zones and paramilitary/police personnel involved in Covid-19 related activities; and c) Asymptomatic household contacts of laboratory confirmed cases,' the advisory said.

Disclaimer: This is an automatically aggregated article/story by a computer program and has not been created or edited by

World COVID19 Meter






Last updated: GMT
sitemap Disclaimer 2019